Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form
- 21 August 2006
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 22 (10) , 1879-1892
- https://doi.org/10.1185/030079906x132613
Abstract
Background: The osmotic-controlled release oral delivery system, OROS, is an advanced drug delivery technology that uses osmotic pressure as the driving force to deliver pharmacotherapy, usually once-daily, in several therapeutic areas.Objective: The purpose of this review is to discuss the evolution of OROS technology and examine the many therapeutic areas where OROS products are being used.Methods: A search of Medline and EMBASE were performed using the keywords ‘OROS’ and ‘osmotic delivery’ for the period January 1990 to June 2005. Data were also obtained from the manufacturers’ websites and associated publications.Results: OROS technology has evolved over the last 30 years, resulting in four systems: the elementary osmotic pump; the two-layer osmotic push–pull tablet; the advanced longitudinally compressed tablet multilayer formulation; and, the L-OROS system. OROS technology is employed for drug delivery in many therapeutic areas including: cardiovascular medicine, endocrinology, urology, and...Keywords
This publication has 46 references indexed in Scilit:
- Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and OxybutyninClinical Pharmacokinetics, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- A Systematic Review of Hydromorphone in Acute and Chronic PainJournal of Pain and Symptom Management, 2003
- The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag‐time after a high fat breakfastBritish Journal of Clinical Pharmacology, 2002
- Effect of Food on Early Drug Exposure from Extended-Release Stimulants: Results from the Concerta®, Adderall XR™ Food Evaluation (CAFÉ) StudyCurrent Medical Research and Opinion, 2002
- Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjectsBiopharmaceutics & Drug Disposition, 2000
- Clinical pharmacokinetics of doxazosin in a controlled‐release gastrointestinal therapeutic system (GITS) formulationBritish Journal of Clinical Pharmacology, 1999
- Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive PatientsJournal of Urology, 1997
- Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDMDiabetes Care, 1994
- Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human SubjectsThe Journal of Clinical Pharmacology, 1981